BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 28447104)

  • 1. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension.
    Thompson AAR; Lawrie A
    Trends Mol Med; 2017 Jan; 23(1):31-45. PubMed ID: 27989641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
    Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
    Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
    Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
    Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S
    Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension.
    Gomez-Puerto MC; Sun XQ; Schalij I; Orriols M; Pan X; Szulcek R; Goumans MJ; Bogaard HJ; Zhou Q; Ten Dijke P
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32531895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
    Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
    Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension.
    Xin Z; Wang J; Li S; Sun C; Jiang W; Xin Q; Wang J; Qi T; Li K; Zhang Z; Luan Y
    Clin Exp Hypertens; 2022 Feb; 44(2):175-180. PubMed ID: 34821188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.
    Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescuing the BMPR2 signaling axis in pulmonary arterial hypertension.
    West J; Austin E; Fessel JP; Loyd J; Hamid R
    Drug Discov Today; 2014 Aug; 19(8):1241-5. PubMed ID: 24794464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.